Fundraising Fox
/Companies
Sign in

Adagene

NASDAQ: ADAG

Founded 2012 · Incorporated in Cayman Islands · 82 employees on LinkedIn · 11 known investors

Find your way into Adagene

Sign up to see every warm intro you have to Adagene

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adagene team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.

AI & Machine LearningBiotech

Investors · 11

F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M

How we know: F-Prime Capital's portfolio page · generalatlantic.com · Not right? Tell us

General Atlanticlisted by General AtlanticNew York · $10M – $1B

How we know: a partner's Signal profile · funding news · generalatlantic.com · Not right? Tell us

Toba Capitallisted by Toba CapitalLos Angeles · $1M – $10M
Sequoia CapitalreportedMenlo Park · $100K – $50M

How we know: prnewswire.com · Not right? Tell us

Also in the syndicate · 6

AVIC TrustGopher Asset ManagementGP Healthcare CapitalKing Star CapitalNew World TMTWuXi AppTec

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

enGeneenGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Enzene Biosciences LtdEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
AntengeneAntengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
OrigeneOriGene develops and manufactures research and diagnostic products, including large-scale GMP antibody production, with R&D and research manufacturing operations. It serves the life sciences and biotech research market from facilities in the US and Germany.
ClementiaIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.

Companies working in the same space as Adagene.

In the news

Adagene Raises $50 Million in Series C Fundingprnewswire.com · Mar 2018

Frequently asked questions

What does Adagene do?
Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
Who are Adagene's investors?
Adagene's investors include Eight Roads Ventures, F-Prime Capital, General Atlantic, Toba Capital, Sequoia Capital.